These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14471082)

  • 1. [What may one expect from bone marrow transfusions in man?].
    MATHE G
    Sem Hop Ther Paris; 1961 Nov; 37():810-2. PubMed ID: 14471082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hematology and cancerology. What can one expect from bone marrow transfusions?].
    BERNARD J; DREYFUS B; HAMBURGER J; MATHE G; SIGUIER F
    Presse Med (1893); 1960 Feb; 68():233-5. PubMed ID: 13799640
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone-marrow transfusions in animals and in man.
    MATHE G
    Triangle; 1960 Jul; 4():219-27. PubMed ID: 13768066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with bone marrow transfusions in malignant diseases].
    WITTE S
    Krebsarzt; 1961 Jun; 16():251-2. PubMed ID: 13786081
    [No Abstract]   [Full Text] [Related]  

  • 5. [POSSIBILITIES OF BONE MARROW TRANSFUSION IN THE TREATMENT OF BONE MARROW DISEASES].
    WITTE S
    Dtsch Med Wochenschr; 1965 Jun; 90():1141-2. PubMed ID: 14306647
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transfusion in blood diseases. (Observations in 9 cases).
    NICOLAU CT; APATEANU V; NICOARA S; GRIGORIU G
    Rum Med Rev; 1961; 5():33-5. PubMed ID: 14479518
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hematological side-effects of cytostatic agents by bone marrow transfusion].
    WITTE S; SCHRICKER KT; MAURER W
    Munch Med Wochenschr; 1960 Jun; 102():1251-3. PubMed ID: 13845471
    [No Abstract]   [Full Text] [Related]  

  • 8. [BONE MARROW TRANSFUSION IN THE TREATMENT OF LYMPHOGRANULOMATOSIS].
    TURBINA NS
    Probl Gematol Pereliv Krovi; 1963 Nov; 8():53-9. PubMed ID: 14140327
    [No Abstract]   [Full Text] [Related]  

  • 9. A simplified method for bone marrow transfusions.
    REICH C
    Acta Haematol; 1958 Dec; 20(6):376-7. PubMed ID: 13616934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with bone marrow transfusions].
    WITTE S
    Dtsch Med Wochenschr; 1961 Jul; 86():1334-7. PubMed ID: 13786082
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems of bone marrow cell transfusions.
    Fliedner TM; Stodtmeister R; Meyer L; Cronkite EP
    Nucl Med (Stuttg); 1963; 2():Suppl 1:445-58. PubMed ID: 4949433
    [No Abstract]   [Full Text] [Related]  

  • 12. A technic of bone marrow transplantation in man.
    SCHWARTZ R; MISRA DK; DAMESHEK W
    Blood; 1960 Jan; 15():137-45. PubMed ID: 14444008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfusion and transplantation of homologous bone marrow in man].
    MATHE G
    Minerva Med; 1961 Jun; 52():2074-80. PubMed ID: 13768069
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplants in man.
    HUMBLE JG
    Med World; 1960 Jan; 92():9-14. PubMed ID: 14403983
    [No Abstract]   [Full Text] [Related]  

  • 15. Transplantation of marrow in man.
    FERREBEE JW; THOMAS ED
    Arch Intern Med; 1960 Oct; 106():523-31. PubMed ID: 13699080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transfusion and grafting of homologous bone marrow in man].
    MATHE G
    Antibiot Chemother; 1960; 8():395-412. PubMed ID: 13768068
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transplantation of bone marrow in generalized irradiation in man].
    MATHE I
    Med Radiol; 1962 Feb; 7():49-58. PubMed ID: 14471083
    [No Abstract]   [Full Text] [Related]  

  • 18. The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations.
    Schultz FW; Martens AC; Hagenbeek A
    Leukemia; 1989 Jul; 3(7):530-4. PubMed ID: 2659903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HEMATOPOIETIC CHIMERISM IN MAN AFTER GRAFT OF ALLOGENIC BONE MARROW. CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE RELATED TO THE CHIMERISM].
    MATHE G; AMIEL JL; SCHWARZENBERG L; CATTAN A; SCHNEIDER M
    C R Hebd Seances Acad Sci; 1963 Nov; 257():3527-9. PubMed ID: 14096502
    [No Abstract]   [Full Text] [Related]  

  • 20. Supralethal whole body irradiation and isologous marrow transplantation in man.
    THOMAS ED; LOCHTE HL; CANNON JH; SAHLER OD; FERREBEE JW
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1709-16. PubMed ID: 13837954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.